Douglas Baum
Directeur/Membre du Conseil chez Regent GLSC Technologies, Inc.
Fortune : 5 534 $ au 30/04/2024
Profil
Douglas R.
Baum was the founder and held the position of Chief Executive Officer & Director at QSAM Biosciences, Inc. which was founded in 2004.
He is currently a Director at Regent GLSC Technologies, Inc. Mr. Baum's former positions include being the President, Chief Executive Officer & Director at Xeris Pharmaceuticals, Inc. from 2012 to 2017.
He also held positions as a Director at Regent Technologies, Inc., SCIREX Corp., Halsa Pharmaceuticals, Inc., and Texas Medical Device Alliance, Inc. Additionally, he was the Vice President at Premier Research Group Ltd.
from 2010 to 2011 and the Senior Vice President-Business Development at Relmada Therapeutics, Inc. Mr. Baum's education history includes undergraduate and graduate degrees from The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/02/2024 | 684 ( 36,99% ) | 5 534 $ | 30/04/2024 | |
-.--% | 02/05/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Douglas Baum
| Sociétés | Poste | Début |
|---|---|---|
Regent GLSC Technologies, Inc.
 Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007. | Directeur/Membre du Conseil | 11/10/2010 |
Anciens postes connus de Douglas Baum
| Sociétés | Poste | Fin |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Fondateur | 02/05/2024 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Directeur Général | 09/01/2017 |
| REGENT TECHNOLOGIES INC | Directeur/Membre du Conseil | - |
| Texas Medical Device Alliance, Inc. | Directeur/Membre du Conseil | - |
| Halsa Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
Formation de Douglas Baum
| The University of Texas at Austin | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Commercial Services |
| SCIREX Corp. | Commercial Services |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
MacuCLEAR, Inc.
 MacuCLEAR, Inc. Pharmaceuticals: MajorHealth Technology MacuCLEAR, Inc. manufactures pharmaceutical products for vascular eye disorders. The company was founded by George C. Y. Chiou and is headquartered in Richardson, TX. | Health Technology |
| Halsa Pharmaceuticals, Inc. | |
| Texas Medical Device Alliance, Inc. | |
Regent Technologies, Inc.
 Regent Technologies, Inc. SemiconductorsElectronic Technology Regent Technologies, Inc. engages in the provision of energy solutions. It develops backup electricity systems for residential and light industrial. The company was founded on January 18, 1980 and is headquartered in Dallas, TX. | Electronic Technology |
Regent GLSC Technologies, Inc.
Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007. | Health Technology |
